We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00210314
First Posted: September 21, 2005
Last Update Posted: March 30, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
International Extranodal Lymphoma Study Group (IELSG)